Oncologic Surgical Emergencies

Antonio Tarasconi is a Consultant General Surgeon, currently working in the Acute Care, Trauma and Emergency Surgery Unit of Parma University Hospital, a tertiary facility and regional trauma hub.  After his graduation with a thesis on the application of Open Abdomen in non-trauma patients, he  worked to improve and extend the general surgeons knowledge in the field acute care and trauma surgery. in his daily clinical practice he  works in collaboration with multiple specialists to provide the best treatment to patients and is actively involved in multiple research projects and clinical trials.Simona Bu is a Medical Oncologist, currently working in the Oncology Department of Parma University Hospital, coordinator of the diagnostic therapeutic protocols and referent oncologist in this hospital for head and neck tumours. For the last 15 yearsshe has been actively inolved in controlled clinical trials in breast, lung, stomach, colon, pancreas, liver,head and neck cancer and supportive care conducted in agreement with GCP.  She also worked as a senologist  and was involved in  breast cancer  follow up and screening programs. At the moment, her research interests are focused on gastrointestinal cancer treatment.Mircea Chirica is an hepatobiliary and oesophageal surgeon currently working as Head of the Hepatobiliary and Liver transplantation Unit in Grenoble. He worked 5 years in the Saint Louis Hospital in Paris where he acquired special expertise in the management of caustic injuries of the upper digestive tract. This resulted in the publication of several original articles in high impact surgical journals (Annals Ann Surg., Br. J Surg, Surg Endosc, World J Surg) and several review papers (Lancet, WJES). He  actually performs supra-mesocolic (liver, pancreas, oesophagus, stomach) oncological procedures and liver transplantation in a hospital which is a Level I trauma center.Gael Roth is associate professor in gastrointestinal oncology, working in the Hepato-gastroenterology and Digestive oncology Department of the Grenoble-Alpes University Hospital (CHUGA). He has a double specialization in gastroenterology and digestive oncology and gained a special expertise on hepatocellular carcinoma, cholangiocarcinoma, pancreatic cancers and ampullary adenocarcinoma. Actively involved in clinical research as an active member of the French National intergroup PRODIGE and within the Fédération Francophone de Cancérologie Digestive, he is coordinating many clinical studies promoted by CHUGA and participates to many national or international trials. In translational research, his fields of expertise are preclinical models, immunology of cancers, and lysine methylation as a mechanism regulating multiple signaling pathways with strong implications in cancer pathogenesis and response to chemotherapy.Jeffry Nahmias is a professor and Chief of the Division of Trauma, Burns, Surgical Critical Care and Acute Care Surgery at the University of California, Irvine. He is board certified in general surgery and surgical critical care and is currently the Director of the Surgical Intensive Care Unit, with his practice evenly split between trauma, surgical critical care, and emergency general surgery as well as elective general surgery. His research interests include multi-institutional trials where he served as the chair of the Eastern Association for the Surgery of Trauma (EAST) multicenters trial committee.

• Head and neck.- Adrenal glands.- Lung.- Esophagus.- Stomach.- Duodenum.- Small Bowel.- Right colon.- Appendix.- Left colon.- Rectum.- Liver.- Pancreas.- Gallbladder and biliary tract.- Spleen.- Uterus and Ovaries.- Kidney.- Urinary Bladder.- Peritoneal carcinosis.- Miscellaneous rare malignancies - Intra-abdominal lymphomas.- Miscellaneous rare malignancies – GIST.- Miscellaneous rare malignancies – Desmoplastic.- Miscellaneous rare malignancies – Sarcomas.- Miscellaneous rare malignancies - Pseudomixoma peritoneum.- Ethical issues.